| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1997-12-18^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-11-09^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff5b371088be46e5fdc3b35a39afa49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f4aba32101f9ef63ce18c769c9afa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabb2913c57578b7f1d80e41e39ddf73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa6893f4c4fb50ccca8b8ad332e393d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_439a9a607e6ad784b0a2c1ac7b78f1ea |
| publicationDate |
1999-11-09^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5981516-A |
| titleOfInvention |
Method of treating menopause or perimenopause |
| abstract |
A method of treating cholesterol without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid of the formula wherein the substituents are defined as in the specification without estrogenic activity at the uterine level. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482813-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6172052-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363071-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0034306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6541464-B2 |
| priorityDate |
1996-12-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |